In the News

In the News

A collection of the most recent news, press mentions, and media assets.

Baptist News Global – May 9, 2023

Sister organization to Colorado nonprofit that pioneered CBD for epileptic seizures exploring psychedelics

Realm of Caring is celebrating its first decade with a report on its achievements, including millions of dollars in aid for hundreds of CBD pilgrims. But the group isn’t stopping there. Its sister organization is now doing pioneering research on the medical benefits of another powerful drug: psilocybin, the naturally occurring compound found in psychedelic mushrooms, or fungi. 


“Psychedelics have a long history of being intermixed with religion and have been used in religious ceremonies for thousands of years,” said Matthew X. Lowe, who leads Realm of Caring’s offshoot, Unlimited Sciences. 

Aspen Public Radio – April 19, 2023

Researchers, Advocates and Medical Professionals Come Together for the Inaugural “Aspen Psychedelic Symposium”

The recent successful state passage of the Natural Medicine Health Act (Proposition 122) represents a massive shift in public perception regarding psychedelics. 


Colorado’s ballot initiative was the first to decriminalize the possession and use of psychedelic mushrooms and certain plant-based psychedelic substances in Colorado law for individuals aged 21 and over, and requires the state to establish a regulated system for accessing psychedelic mushrooms and additional plant-based psychedelic substances.


Benzinga- March 17, 2023

Cannabis saved my kid. Psychedelics saved me


What is the most powerful force in the world?


Of course, it is love, but what kind of love? Not a single doubt – it is a parent’s love for their children.

One person, one mother that has proven this to be true is Heather Jackson, an international speaker, author and published researcher. She is also the co-founder and president of the Realm of Caring Foundation (RoC), a cannabis-focused non-profit that helps families struggling with life-limiting and chronic health conditions through research education and grants.

Alive Magazine – January 31, 2023

Plant Allies for Mental Health

Realm of Caring, a non-profit dedicated to cannabis research and education, has partnered with John Hopkins University to gather longitudinal data on how cannabis use affects various health and quality of life markers. 


In addition to Realm of Caring, Lowe heads up research at Unlimited Sciences, a psychedelic research non-profit. In another collaboration with John Hopkins University, they’re conducting an extensive study on real-world psilocybin use to better understand positive and negative outcomes.  

Ganjapreneur – December 15, 2022

2023 Cannabis Industry Predictions: Cultivation, Agtech, Science, Hemp, & Psychedelics

In the coming year, we’ll see initiatives bolster research examining the therapeutic potential of psychedelics in treating a range of mental health conditions, and solidify psychedelic therapy as the next frontier in mental health treatment. However, research continues to be held back by bureaucratic red tape and funding limitations, and widespread efforts to increase profitability in the psychedelics industry will fuel heightened tensions between corporate- and community-based approaches to psychedelic access. 

High Times – November 10, 2022

Colorado Voters Approve Psychedelics Decriminalization Measure


Psychedelics such as psilocybin, mescaline, and DMT have also been used for centuries by indigenous American cultures for medicinal and spiritual purposes. Matthew X. Lowe Ph.D., research director at psychedelic research nonprofit Unlimited Sciences, says that there are numerous health and wellness benefits “that come from consuming psilocybin.”

Nutrition Insight – October 20, 2022

Make way for magic mushrooms: Colorado to vote on psychedelics legalization amid mental health crisis


The US State of Colorado is preparing to vote this November on whether to legalize healing centers using magic mushrooms for treatments amid surging mental health concerns worldwide. The vote will also include whether to decriminalize the possession, growing and sharing of hallucinogenic plants and fungi for personal use. 


“We are facing a worldwide mental health epidemic, and new treatment methods are critically needed to overcome the shortcomings of traditional treatments. Psychedelics have the potential to shift this trajectory positively,” Matthew X. Lowe, director of research for Unlimited Sciences, tells NutritionInsight.

Ethos – October 18, 2022

Americans Want Psychedelic Treatments for Depression. Will Legislation Catch Up?


Ayahuasca, the DMT-rich brew used widely across South America, is seeing an uptick in research, too. Psychedelic magazine DoubleBlind reports that a new study will see immigrants and refugees trial ayahuasca to process trauma. That research is being helmed by Unlimited Sciences out of Colorado Springs, Colorado.


“We thought this would be a fantastic opportunity to be able to educate and bring awareness to both the positive and negative experiences of these group-based ceremonies,” Matthew X. Lowe, director of research at Unlimited Sciences told DoubleBlind.

Forbes – September 21, 2022

Colorado Will Vote On Legalizing Psychedelic Mushrooms In November


Matthew X. Lowe Ph.D., research director at psychedelic research nonprofit Unlimited Sciences, says that there are numerous health and wellness benefits “that come from consuming psilocybin.”


“Preindustrial Mesoamerican cultures have consumed psilocybin for thousands of years in ritualized contexts to enhance psychotherapeutic healing, religious insight, and self-exploration,” he writes in an email. “In recent years, there has been renewed interest in the therapeutic potential of psilocybin in treating a range of different psychiatric disorders, including depression, anxiety, suicidality, substance use disorders, and obsessive-compulsive disorder, among others.”

The Daily Beast – September 16, 2022

Forget Weed. Legal Shrooms, DMT, and Mescaline May Be Next.


Unlimited Sciences, a Colorado-based nonprofit organization that researches psychedelic drug use, is currently working with 8,000 study participants, 1,000 of whom have completed a five-month prospective observational study. Del Jolly, the group’s appropriately named co-founder, said their “very preliminary” research into psychedelic drug use since Denver decriminalized psilocybin at the local level in 2019 suggested that the average user was 39.5 years old.

Psychedelic Spotlight – August 24, 2022

Can an Ayahuasca Ceremony Heal Immigrant and Refugee Trauma?


In an airy room overlooking the mountains, soft voices and the smell of sage surround an altar with carefully placed crystals, candles, instruments, and sacred herbs. The pale sun is low on the horizon, casting long shadows as each attendant is cleansed with sage and invited to take their place in the circle. Pillows, blankets, and mats encircle the room, reminiscent of an inviting childhood slumber party. The individuals seated in the circle are mostly Arabic-speaking women from the Middle East and North Africa (MENA), including immigrants and refugees of various backgrounds originating from Saudi Arabia, Iraq, Morocco, and the United Arab Emirates.

Filter Magazine – August 18, 2022

Can Ayahuasca Help to Heal Refugees’ Trauma?


A new study will seek to discover if ayahuasca is effective at helping a group of Middle Eastern and North African refugees, primarily women, to heal from trauma. While previous research has examined the effectiveness of ayahuasca for trauma, it hasn’t touched this population from a region of the world that has seen much warfare and and suffering.


Maleek Asfeer, a Saudi Arabian filmmaker now based in Colorado, organized an ayahuasca ceremony and reached out to the researchers to offer them the chance to collect data on it. The study was approved by the FDA and is being conducted in accordance with HIPAA patient privacy rules.

Healio – August 11, 2022

Study to Investigate Ayahuasca’s Effects on Trauma Linked to Migration


Psychedelic research nonprofit Unlimited Sciences announced a new study that intends to measure the potential healing effects of ayahuasca on refugees and immigrants with past experiences of trauma.


According to a company release, the study — expected to commence this summer — will engage mostly female immigrants and refugees seeking remedial therapy through the psychoactive hallucinogenic, which has been identified as a candidate for the treatment of trauma.

CPR News – August 16, 2022

Stressed out, busy moms say microdosing mushrooms makes life easier and brighter. Researchers caution that they are ‘experimenting on themselves’


Heather Jackson calls it the mother’s wall and it usually comes on very suddenly. 


She can’t make regular decisions, like what to cook for dinner. She realizes the kitchen trash is full and starts to go to take it out and then discovers something else needs to be done and she sets the trash bag down, only to discover it eight hours later. 


“I can feel the wall coming,” said Jackson, CEO of Unlimited Sciences, a psychedelic research company and a mother of two in a town south of Denver. “And I think the wall is coming because I need something to rest on.”

Benzinga – August 10, 2022

Psychedelic Treatments Vary Greatly By Cost And Setting, What About Efficacy?


“It’s essential that modern retreat centers learn from indigenous practices and understand how to mitigate the risk of harm,” Matthew X. Lowe Ph.D., research director for Colorado-based psychedelics research nonprofit Unlimited Sciences.


At the same time, calls for access are made as concerns over affordable pricing and indigenous inclusion remain.

High Times – July 27, 2022

DEA Rescinds Proposal to Ban Five Psychedelic Drugs


Matthew X. Lowe Ph.D., research director at the psychedelic research nonprofit organization Unlimited Sciences, tells High Times that the psychedelic drugs that the DEA had sought to ban have therapeutic potential that should be explored through research.


“The compounds 4-OH-DiPT, 5-MeO-AMT, 5-MeO-MiPT, 5-MeO-DET and DiPT are lesser-known psychedelic substances of the tryptamine class,” Lowe wrote in an email. “The effects of these psychedelic compounds on humans were first documented by Alexander and Ann Shulgin, who famously synthesized and studied the effects of these and hundreds of other psychoactive compounds.”

The Emerald Magazine – June 22, 2022

The Next Steps in Psychedelic Health Treatment


Another psychedelic research group looking to gain more knowledge about psychedelic treatment is Unlimited Sciences. Formed in 2018 by Heather Jackson, Unlimited Sciences has a goal to create the world’s largest collection of real-world data surrounding psychedelics. They hope to use this resource to develop an understanding of how to use psychedelics safely and effectively.


In 2018, Unlimited Sciences partnered with John Hopkins University, the largest psilocybin registry in the world, to conduct an observational research study on psychedelic treatment.

High Times – August 8, 2022

Normalizing Psychedelics: An Interview with Matthew X. Lowe


Over the past few years, psychedelics are finally becoming more normalized, but for the most part, that just means psilocybin. LSD is still considered, even by many who are interested in the world of mushrooms and cannabis, to be a taboo substance. Unlimited Sciences and Matthew X. Lowe would love to change that. We chatted with him about the moves he’s been making to change the culture and bring psychedelics access to those who need it.

Ganjapreneur – June 1, 2022

Matthew X. Lowe: Advancing Medicinal Cannabis and Psychedelics Research


Ganjapreneur recently connected with Matthew X. Lowe, the Research Director for Realm of Caring and for Unlimited Sciences — which is a psychedelics research firm — to discuss cannabis and psychedelics medicinal research. This interview covers why this research is necessary, who benefits from it, the methods used to understand the healing possibilities of these compounds, and more!

VICE – February 11, 2022

How to Microdose Drugs Based on What You’re Using


Another reason to go slow—whether microdosing once or repeatedly over the course of several days, weeks, or months—is to prevent building up a tolerance. It’s best to wait a few days after microdosing before taking anything again, said Matthew X. Lowe, research director for the psychedelic research non-profit Unlimited Sciences, which is currently conducting a study on the health outcomes associated with full-dose psilocybin with Johns Hopkins University. “It is a commonly practiced three-day cycle that follows the ‘Fadiman Schedule’, where for 48 hours, you remain substance-free,” he said, “and on the third day, you microdose.”

Benzinga – March 6, 2022

The Road to Psychedelics Legalization


In the midst of a psychedelic renaissance, it’s crucial to recognize that the use of psychedelics is not a new phenomenon. But what has changed in recent years is a concerted effort to increase our scientific understanding of their applications in natural medicine and therapeutic healing—and everyone who’s interested can play a part.

The colorful road to psychedelics legalization has been intertwined with human history for thousands of years. Anthropological reports indicate that psychoactive substances in the form of plants, fungi, roots, seeds, and even the secretions of animals have been used by humans for millennia. 

Join our Mailing list!

Our newsletter is meant to provide you with the latest news in psychedelic research, inform you about our work, and inspire you with compelling stories from all over the world about the power of psychedelics.